|
HAMPSHIRE MEDICAL TRADING COMPANY LIMITED
REGISTERED NUMBER: 02288634
STATEMENT OF FINANCIAL POSITION
AS AT 30 APRIL 2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due within one year
|
|
|
|
|
Net current assets/(liabilities)
|
|
|
|
|
Total assets less current liabilities
|
|
|
|
|
Creditors: amounts falling due after more than one year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes
Hampshire Medical Trading Company Limited is a private company limited by shares registered in England and Wales number 02288634. Its registered office is situated at Alendale, Uckfield Lane, Hever, Edenbridge, Kent TN8 7LJ.
Average number of employees
|
The average monthly number of employees, including directors, during the year was 1 (2024 - 1).
Guarantees and other financial commitments
|
The company has future financial commitments in respect of bank borrowings. Future interest charges not disclosed in these accounts is as follows: bank loan one interest charges amounts to £276,680 and bank loan two interest charges amounts to £184,453. Additionally, the financial commitment in respect of future ground rents amounts to £200,211.
Directors' confirmations
The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.
|
|
HAMPSHIRE MEDICAL TRADING COMPANY LIMITED
REGISTERED NUMBER: 02288634
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 30 APRIL 2025
The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved and authorised for issue by the board and were signed on its behalf on 28 October 2025.
|